↓ Skip to main content

Cochrane Database of Systematic Reviews

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

Overview of attention for article published in Cochrane database of systematic reviews, October 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
124 Mendeley
Title
Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients
Published in
Cochrane database of systematic reviews, October 2012
DOI 10.1002/14651858.cd007913.pub2
Pubmed ID
Authors

Peter Renner, Stefania Milazzo, Jian Ping Liu, Marcel Zwahlen, Josef Birkmann, Markus Horneber

Abstract

High-dose or dose-intensive cytotoxic chemotherapy often causes myelosuppression and severe neutropenia among cancer patients. Severe neutropenia accompanied by fever, named febrile neutropenia (FN), is the most serious manifestation of neutropenia usually requiring hospitalization and intravenous antibiotics. FN and neutropenia can lead to chemotherapy treatment delays or dose reductions, which potentially compromises the effectiveness of cancer treatment and prospects for a cure. Granulocyte-macrophage (GM) and granulocyte colony-stimulating factors (G-CSFs) are administered during chemotherapy in order to prevent or reduce the incidence or the duration of FN and neutropenia.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 123 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 16%
Student > Master 16 13%
Student > Bachelor 14 11%
Other 9 7%
Student > Doctoral Student 9 7%
Other 28 23%
Unknown 28 23%
Readers by discipline Count As %
Medicine and Dentistry 43 35%
Nursing and Health Professions 16 13%
Biochemistry, Genetics and Molecular Biology 9 7%
Agricultural and Biological Sciences 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 15 12%
Unknown 32 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2012.
All research outputs
#10,024,007
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,434
of 8,923 outputs
Outputs of similar age
#101,226
of 143,152 outputs
Outputs of similar age from Cochrane database of systematic reviews
#69
of 77 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,152 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.